Prediction of human oral cancer radiation responsiveness by histone (H3) mRNA in situ hybridization: A preliminary report

Journal of Oral and Maxillofacial Surgery

Volumn 56, Issue 12, 1998, Pages 1410-1416

  Donoff, R Bruce ^a,b   Todd, Randy ^a,b   Elovic, Aram ^a   Gallagher, George T ^a   Chou, Ming Yung ^c   Wong, David T W ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; MESSENGER RNA;

ADULT; AGED; ARTICLE; BEAM THERAPY; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LABELING INDEX; MALE; MOUTH CARCINOMA; PREDICTION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

EID: 0031728344     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2391(98)90406-2     Document Type: Article

References (29)

1. Wang CC: in Wang CC (ed): Radiation Therapy for Head and Neck Neoplasms: Indications, Techniques and Results. Littleton, MA, Year Book Medical Publisher, 1990
2. Vokes EE, Weichselbaum RR, Lippman SM, et al: Head and neck cancer. N Engl J Med 328:184, 1993
3. Yuen AP, Wei WI, Lam LK, et al: Results of surgical salvage of locoregional recurrence of carcinoma of the tongue after radiotherapy failure. Ann Otol Rhinol Laryngol 106:779, 1997
4. Peters LJ, Brock WA, Chapman JD, et al: Predictive assays of tumor radiocurability. Am J Clin Oncol 11:275, 1988
5. Lichter AS, Lawrence TS: Recent advances in radiation oncology. N Engl J Med 332:371, 1995
6. Chauvel P, Courdi A, Gioanni J, et al: The labeling index: A prognostic factor in head and neck carcinoma. Radiother Oncol 14:231, 1989
7. Raybaud-Diogene H, Fortin A, Morency R, et al: Markers of radioresistance in squamous cell carcinomas of the head and neck: A clinicopathologic and immunohistochemical study. J Clin Oncol 15:1030, 1997
8. Hall EJ: Predictive Assays: Radiobiology for the Radiobiologist. Philadelphia, PA, Lippincott, 1994, pp 245-256
9. Chauvel P, Courdi A, Gioanni J, et al: The labelling index: A prognostic factor in head and neck carcinoma. Radiother Oncol 14:231, 1989
10. Wong DTW, Chou MY, Chang LC, et al: Use of intracellular H3 messenger RNA as a marker to determine the proliferation pattern of normal and 7,12-dimethylbenz[a]anthracene-transformed hamster oral epithelium. Cancer Res 50:5107, 1990
11. Chou MY, Chang AL, McBride J, et al: A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization. Am J Pathol 136:729, 1990
12. Bosch FX, Udvarhelyi N, Venter E, et al: Expression of the histone H3 gene in benign, semi-malignant and malignant lesions of the head and neck: A reliable proliferation marker. Eur J Cancer 29A:1454, 1993
13. Cleveland DW, Lopata MA, MacDonald RJ, et al: Number and evolutionary conservation of a and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell 20:95, 1980
14. Ritter MA: New approches to cell kinetics in human tumors. Curr Probl Cancer 17:327, 1993
15. Suit HD: Local control and patient survival. Int J Radiat Oncol Biol Phys 23:653, 1992
16. Munck-Wikland E, Fernverg J-O, Kuylenstierna R, et al: Proliferating cell nuclear antigen (PCNA) expression and nuclear DNA content in predicting recurrence after radiotherapy of early glottic cancer. Oral Oncol Eur J Cancer 29B:75, 1993
17. Peters LJ, Brock WA, Travis EL: Radiation biology at clinically relevant fractions. Important Adv Oncol 65-83, 1990
18. Nagao T, Ishida Y, Kondo Y: Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: Correlation with histologic grade and other cell proliferative markers. Mod Pathol 9:99, 1996
19. 3H]thymidine techniques to measure cell proliferation. Cell Tissue Kinet 14:111, 1981
20. Smith MD, Healy E, Thompson V, et al: Use of in situ detection of histone mRNA in the assessment of epidermal proliferation: Comparison with the Ki-67 antigen and BrdU incorporation. Br J Dermatol 132:359, 1995
21. Gown AM, Jiang JJ, Matles H, et al: Validation of the S-phase specificity of histone (H3) in situ hybridization in normal and malignant cells. J Histochem Cytochem 44:221, 1996
22. van Dierendonck JH, Keijzer R, Cornelisse CJ: Nuclear distribution of the Ki-67 antigen during the cell cycle: Comparison with the growth fraction in human breast cancer cells. Cancer Res 49:2999, 1989
23. Denijn M, Schuurman HJ, Jacobse KC, et al: In situ hybridization: A valuable tool in diagnostic pathology. APMIS 100:669, 1992
24. Coffino P, Stimac E, Groppi VE, et al: Histone gene expression and the mammalian cell cycle, in Stein GS, Stein JL, Marzluff WF (eds): Histone Genes: Structure, Organization, and Regulation. New York, NY, Wiley-Interscience Publication, 1984
25. Konishi H, Steinback G, Terry JHA, et al: Histone H3 messenger RNA in situ hybridization correlates with in vivo bromodeoxyuridine labeling of S-phase cells in rat colonic epithelium. Cancer Res 56:434, 1996
26. Denekamp J: Cell kinetics and radiation biology. Int J Radiat Biol 49:357, 1986
27. Malaise EP, Chavaudra N, Tubiana M: The relationship between growth rate, labelling index and histological type of human solid tumors. Eur J Cancer 9:305, 1973
28. Willett CG, Warland G, Hagan MP, et al: Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 13:1417, 1995
29. Oka K, Nakano T, Hoshi T: Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma: MIB-1 and PC10 labeling indices. Cancer 77:2280, 1996